The New England Journal of Medicine announces that Azidothymidine produces synergistic activity in combination with Colistin against antibiotic-resistant Enterobacteriaceae. Antimicrobial Agents Chemother. doi:10.1128/AAC.01630-18. The NEJM review entitled Colistin-Azidothymidine synergy against Enterobacteriaceae suggests that azidothymidine may have a future role against Enterobacteriaceae, particularly for urinary tract infections.
click here to subscribe & read the full article. https://www.jwatch.org/na48250/2019/01/09/colistin-azidothymidine-synergy-against-enterobacteriaceae